Morgan Stanley Biomea Fusion, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Morgan Stanley holds 480,080 shares of BMEA stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

480,080

Previous 462,358 3.83%

Holding current value

$1.2 Million

Previous $1.79 Million 43.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.13 - $4.48 $37,747 - $79,394	17,722 Added 3.83%	480,080 $1.02 Million
Q4 2024 Feb 14, 2025	SELL	$3.88 - $12.41 $172,477 - $551,661	-44,453 Reduced 8.77%	462,358 $1.79 Million
Q3 2024 May 14, 2025	BUY	$4.23 - $10.1 $168,633 - $402,646	39,866 Added 8.54%	506,811 $5.12 Million
Q3 2024 Nov 14, 2024	BUY	$4.23 - $10.1 $168,633 - $402,646	39,866 Added 8.54%	506,811 $5.12 Million
Q2 2024 May 14, 2025	BUY	$4.14 - $15.3 $18,990 - $70,181	4,587 Added 0.99%	466,945 $2.1 Million
Q2 2024 Oct 17, 2024	BUY	$4.14 - $15.3 $39,429 - $145,717	9,524 Added 2.08%	466,945 $2.1 Million
Q2 2024 Aug 14, 2024	BUY	$4.14 - $15.3 $39,429 - $145,717	9,524 Added 2.08%	466,945 $2.1 Million
Q1 2024 Oct 17, 2024	SELL	$13.92 - $19.5 $132,574 - $185,718	-9,524 Reduced 2.04%	457,421 $6.84 Million
Q1 2024 Aug 16, 2024	SELL	$13.92 - $19.5 $292,055 - $409,129	-20,981 Reduced 4.39%	457,421 $6.84 Million
Q1 2024 May 15, 2024	SELL	$13.92 - $19.5 $292,055 - $409,129	-20,981 Reduced 4.39%	457,421 $6.84 Million
Q4 2023 Aug 16, 2024	BUY	$8.37 - $19.8 $95,895 - $226,848	11,457 Added 2.45%	478,402 $6.95 Million
Q4 2023 Feb 13, 2024	BUY	$8.37 - $19.8 $2.07 Million - $4.89 Million	246,937 Added 106.68%	478,402 $6.95 Million
Q3 2023 Nov 15, 2023	BUY	$13.44 - $23.02 $1.62 Million - $2.77 Million	120,223 Added 108.07%	231,465 $3.18 Million
Q2 2023 Aug 14, 2023	SELL	$21.66 - $41.8 $129,505 - $249,922	-5,979 Reduced 5.1%	111,242 $2.44 Million
Q1 2023 May 15, 2023	BUY	$6.8 - $32.35 $6,915 - $32,899	1,017 Added 0.88%	117,221 $3.64 Million
Q4 2022 Feb 14, 2023	BUY	$6.3 - $11.6 $81,767 - $150,556	12,979 Added 12.57%	116,204 $979,000
Q3 2022 Nov 14, 2022	SELL	$9.51 - $13.61 $171,978 - $246,123	-18,084 Reduced 14.91%	103,225 $1.01 Million
Q2 2022 Oct 27, 2022	BUY	$3.0 - $12.03 $308,847 - $1.24 Million	102,949 Added 560.72%	121,309 $1.45 Million
Q2 2022 Aug 15, 2022	BUY	$3.0 - $12.03 $308,847 - $1.24 Million	102,949 Added 560.72%	121,309 $1.45 Million
Q1 2022 Oct 27, 2022	SELL	$4.39 - $9.03 $451,946 - $929,629	-102,949 Reduced 84.87%	18,360 $82,000
Q1 2022 May 13, 2022	SELL	$4.39 - $9.03 $38,056 - $78,281	-8,669 Reduced 32.07%	18,360 $82,000
Q4 2021 Feb 14, 2022	BUY	$7.22 - $12.72 $132,660 - $233,717	18,374 Added 212.29%	27,029 $201,000
Q3 2021 Nov 15, 2021	BUY	$10.0 - $15.99 $86,550 - $138,393	8,655 New	8,655 $103,000

Others Institutions Holding BMEA

# of Institutions

109

Shares Held

16.1M

Call Options Held

229K

Put Options Held

354K

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $72.9M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account